{"database": "lobbying", "table": "lobbying_activities", "rows": [[2963314, "2a83cbd8-437c-4bf2-99fd-71868810c832", "Q1", "BLUEBIRD STRATEGIES", 401105447, "MYRIAD GENETICS, INC.", 2023, "first_quarter", "MED", "Legislation to regulate clinical labs under CLIA and FDA.", "HOUSE OF REPRESENTATIVES,SENATE", 0, 0, "2023-04-18T09:27:57-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2963314"], "units": {}, "query_ms": 34.523197973612696, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}